CURX
Curanex Pharmaceuticals Inc Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$14.99M
P/E Ratio
—
EPS
$-0.02
Beta
—
52W High
$9.18
52W Low
$0.26
50-Day MA
$0.39
200-Day MA
$1.13
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Curanex Pharmaceuticals Inc Common Stock
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. The company is headquartered in Jericho, New York.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -85.30% |
| Return on Assets | -30.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.01 |
| Price-to-Book | 1.24 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $28.34M |
| Float | $8.91M |
| % Insiders | 67.81% |
| % Institutions | 0.00% |
Data last updated: 4/7/2026